All‐cause mortality · prevention of SCI in people with SCD and normalised TCD velocities
It is very uncertain whether transfusions continued changes all‐cause mortality compared with transfusions halted (very low certainty).
1 finding from 1 review
All‐cause mortality · prevention of SCI in people with SCD and normal TCD velocities
1 finding from 1 review
All‐cause mortality · prevention of SCI in people with SCD who have not had a stroke (primary prevention)
1 finding from 1 review
no estimate extracted
1 study · 1 participants
Very low
All‐cause mortality · prevention of SCI in people with SCD who had a stroke (secondary prevention)
It is very uncertain whether hydroxyurea changes all‐cause mortality compared with RBC transfusion (very low certainty).
1 finding from 1 review
All‐cause mortality · prevention of SCI in people with SCD and abnormal TCD velocities
1 finding from 1 review
All‐cause mortality · adults with heart failure
Multidisciplinary disease management programmes probably leads to lower all‐cause mortality compared with usual care (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults with heart failure
Case management may leads to lower all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
All‐cause mortality · adults with heart failure
Clinic‐based intervention showed no clear difference in all‐cause mortality compared with usual care (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · newborn infants at risk of gastrointestinal bleeding
It is very uncertain whether the intervention changes all‐cause mortality (very low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · infants with upper gastrointestinal bleeding
The intervention showed no clear difference in all‐cause mortality (low certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality · people suffering from high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · people suffering from high altitude illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · children (aged 6 to 11 years) being overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · adolescents (aged 12‐17 years) being overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes all‐cause mortality compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Intervention not reported
All‐cause mortality · adults with type 2 diabetes and severe mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · preschool children (aged 0 to 6 years) with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · obese children and adolescents
1 finding from 1 review